Edesa Biotech (EDSA) Non-Current Assets (2013 - 2026)
Edesa Biotech (EDSA) posted Non-Current Assets of $1.94 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 5.0% from $2.04 million a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech's Non-Current Assets came in at $2.02 million, down 5.6% from FY2024.
- Annual Non-Current Assets has declined for five consecutive fiscal years, with a five-year compound annual growth rate of -5.4% (FY2020 to FY2025).
- In prior fiscal years, Edesa Biotech's Non-Current Assets was $2.14 million in FY2024 (-12.8%), $2.45 million in FY2023 (-1.2%), $2.48 million in FY2022 (-0.4%) and $2.49 million in FY2021 (-6.2%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Non-Current Assets since fiscal Q2 2020.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was fiscal Q3 2023, with growth of 6.1%; the weakest was fiscal Q1 2025, with a decline of 13.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.18 Mn |
| Mar 31, 2024 | 2.23 Mn |
| Dec 31, 2023 | 2.42 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 2.54 Mn |
| Dec 31, 2022 | 2.59 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 2.36 Mn |
| Mar 31, 2022 | 2.41 Mn |
| Dec 31, 2021 | 2.45 Mn |
| Sep 30, 2021 | 2.49 Mn |
| Jun 30, 2021 | 2.54 Mn |
API Access
Edesa Biotech Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();